Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT04213118
Status:
UNKNOWN
Last Update Posted:
2023-01-17
First Post:
2019-12-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-25
First Submit QC Date:
None
Study First Post Date:
2019-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-12
Last Update Post Date:
2023-01-17
Last Update Post Date Type:
ACTUAL